<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02490696</url>
  </required_header>
  <id_info>
    <org_study_id>CHB14.01</org_study_id>
    <nct_id>NCT02490696</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer</brief_title>
  <acronym>RTEP6</acronym>
  <official_title>Comparative Study of the Hypoxia Measured in FAZA and F-miso TEP/CT Scan in Patients With Non-small Cell Lung Cancer at the Time of Diagnosis : Correlation With Immunohistochemistry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Henri Becquerel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Henri Becquerel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the intratumoral biodistribution of FAZA and F-miso in&#xD;
      patients with non-small cell lung cancer and correlate the results of PET scans with&#xD;
      immunohistochemistry.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to compare the biodistribution of the two tracers specific for&#xD;
      hypoxia in patients with non-small cell lung cancer.&#xD;
&#xD;
      Two PET scans will be performed with FAZA and F-Miso tracers. The time between these twi PET&#xD;
      scans will be 24 hours.&#xD;
&#xD;
      another 24 hours after the late PET scan, the surgery will be done and a piece of tumor will&#xD;
      be collected.&#xD;
&#xD;
      Piece of tumor will be analysed by immunohistochemistry for hypoxia markers.&#xD;
&#xD;
      The results of immunohistochemistry will be correlated with the biodistribution of the two&#xD;
      tracers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">October 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of hypoxia with FAZA and F-Miso tracer</measure>
    <time_frame>one year</time_frame>
    <description>SUV max, SUV mean and SUV peak were calculated for FAZA PET and Fmiso PET and will be correlated with results of immunohistochemistry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>one year</time_frame>
    <description>time between inclusion and the death whatever the cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>disease-free survival</measure>
    <time_frame>one year</time_frame>
    <description>time between inclusion and the progression or death</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Miso</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm two PET scans wiil be realized. The first one will be made with F-Miso tracer. 24 hours later the FAZA PET scan will be performed. 24 hours after the last PET scan the surgery will be realized. During this surgery a piece of tumor will be collected and analyse by immunohistochemistry for markers of hypoxia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FAZA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm two PET scans wiil be realized. The first one will be made with FAZA tracer. 24 hours later the F-Miso PET scan will be performed. 24 hours after the last PET scan the surgery will be realized. During this surgery a piece of tumor will be collected and analyse by immunohistochemistry for markers of hypoxia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Miso PET scan</intervention_name>
    <description>2 PET scans will be performed before surgery : the first one with F-Miso tracer and the second, 24 hours later, with FAZA tracer</description>
    <arm_group_label>Miso</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FAZA PET scan</intervention_name>
    <description>2 PET scans will be performed before surgery : the first one with FAZA tracer and the second, 24 hours later, with F-Miso tracer</description>
    <arm_group_label>FAZA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  More than 18 years old&#xD;
&#xD;
          -  Patient with non-small cell lung cancer (histologically proved)&#xD;
&#xD;
          -  PS inferior or equal to 1 (good general state)&#xD;
&#xD;
          -  Patient must have surgery for their non-small cell lung cancer&#xD;
&#xD;
          -  Stage of tumor Superior or equal to 2a without metastasis&#xD;
&#xD;
          -  Tumoral fixation with 18-FDG-PET superior to mediastinal background noise&#xD;
&#xD;
          -  Written inform consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Histology other than primitive non-small cell lung cancer&#xD;
&#xD;
          -  In situ form at the histological study&#xD;
&#xD;
          -  Patient without evaluable target&#xD;
&#xD;
          -  No fixation on the pretherapeutic FDG-PET scan&#xD;
&#xD;
          -  PS Superior or equal to 2&#xD;
&#xD;
          -  neoplastic disease (less than 2 years or progressive)&#xD;
&#xD;
          -  Pregnant woman or child-bearing&#xD;
&#xD;
          -  Patient Under guardianship or curators&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Vera, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Henri Becquerel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 2, 2015</study_first_submitted>
  <study_first_submitted_qc>July 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2015</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PET scan</keyword>
  <keyword>FAZA</keyword>
  <keyword>F-Miso</keyword>
  <keyword>hypoxia</keyword>
  <keyword>lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

